New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.

New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.

Guidelines recommend routine screening for colorectal cancer (CRC) in asymptomatic adults starting at age 50. The most extensively used noninvasive test for CRC screening is the fecal immunochemical test (FIT), which has an overall sensitivity for CRC of approximately 61.0%-91.0%, which drops to 27....

Full description

Bibliographic Details
Main Authors: Marta Malagón, Sara Ramió-Pujol, Marta Serrano, Joan Amoedo, Lia Oliver, Anna Bahí, Josep Oriol Miquel-Cusachs, Manel Ramirez, Xavier Queralt-Moles, Pau Gilabert, Joan Saló, Jordi Guardiola, Virginia Piñol, Mariona Serra-Pagès, Antoni Castells, Xavier Aldeguer, L Jesús Garcia-Gil
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0243158

Internet

https://doi.org/10.1371/journal.pone.0243158

Similar Items